The Business Times
business-time-50

Abbott

Companies & Markets

Abbott raises 2026 profit forecast on strength in diagnostics, heart devices

2026-07-16T13:08:41.000Z
Intermittent use of continuous glucose monitors has yielded good results.
Travel & Wellness
HEALTH

A short-term monitoring method that’s driving habit change for Singapore’s diabetics

2026-06-25T04:00:00.000Z
Abbott expects full-year adjusted earnings of US$5.38 to US$5.58 a share, against its previous forecast of US$5.55 to US$5.80.
Companies & Markets

Abbott cuts profit forecast in wake of cancer-screening deal

2026-04-16T13:43:18.000Z
The company now expects annual adjusted profit between US$5.12 and US$5.18 per share, compared to its previous range of US$5.10 to US$5.20.
Companies & Markets

Abbott posts higher quarterly revenue on strong medical device demand

2025-10-15T13:44:29.000Z
It's the first victory for the companies as they face more than 1,000 similar cases and both have previously lost trials, including one that ended with an almost US$500 million verdict against Abbott in July.
Consumer & Healthcare

Abbott, Reckitt unit defeat claims in baby formula trial

2024-11-01T09:59:35.000Z
Illinois resident Margo Gill, who brought the case against Abbott, alleged that the company failed to warn that its formula could cause a potentially deadly disease called necrotizing enterocolitis (NEC) in premature babies.
Consumer & Healthcare

Abbott must pay US$495 million in premature infant formula trial, jury finds

2024-07-27T00:47:08.000Z
Sales of Abbott's medical devices rose 10.2 per cent to US$4.66 billion, beating the average estimate.
Consumer & Healthcare

Abbott raises annual profit forecast as strong medical device sales power quarterly beat

2024-07-18T12:57:35.000Z
The devices, one for the health-conscious and another for those with diabetes, follow Abbott’s FreeStyle Libre, which generates over US$1 billion every quarter and is sold under prescription for patients with diabetes.
Consumer & Healthcare

Abbott secures FDA clearance for two over-the-counter glucose monitors

2024-06-10T16:20:00.000Z
Profit rose to 2.87 billion rupees (S$46.5 million) for the three months ended March 31, from 2.31 billion rupees a year earlier.
Companies & Markets

Drugmaker Abbott India posts Q4 profit rise on higher sales

2024-05-09T13:50:17.000Z
Sales of Abbott’s medical devices have been strengthened in recent quarters due to a resurgence in the demand for joint replacements as well as other surgeries that were delayed during the Covid-19 pandemic.
Consumer & Healthcare

Abbott beats quarterly profit estimates on strong medical device sales

2024-04-17T12:06:34.000Z
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More